首页 | 本学科首页   官方微博 | 高级检索  
   检索      


High yield expression in a recombinant <Emphasis Type="Italic">E. coli</Emphasis> of a codon optimized chicken anemia virus capsid protein VP1 useful for vaccine development
Authors:Meng-Shiou?Lee  You-Cheng?Hseu  Guan-Hua?Lai  Wen-Te?Chang  Hsi-Jien?Chen  Chi-Hung?Huang  Meng-Shiunn?Lee  Min-Ying?Wang  Jung-Yie?Kao  Bang-Jau?You  Wen-?Hsin?Lin  Email author" target="_blank">Yi-Yang?LienEmail author  Email author" target="_blank">Ming-Kuem?LinEmail author
Institution:1.School of Chinese Pharmaceutical Sciences and Chinese Medicine Resources,China Medical University,Taichung,Taiwan;2.Dept. of Cosmeceutics,College of Pharmacy, China Medical University,Taichung,Taiwan;3.Graduate Institute of Biotechnology, College of Agriculture and Natural Resources, National Chung Hsing University,Taichung,Taiwan;4.Dept. of Safety, Health and Environmental Engineering,Mingchi University of Technology,Taichung,Taiwan;5.Graduate School of Biotechnology, Hung kuang University,Taichung,Taiwan;6.Department of Medical Research,Tung's Taichung MetroHarbor Hospital,Taichung,Taiwan;7.Institute of Biochemistry, College of Life Science, National Chung Hsing University,Taichung,Taiwan;8.School of Pharmacy Undergraduate Program,Master Degree Program, Ph.D Program, China Medical University,Taichung,Taiwan;9.Dept. of Veterinary Medicine,National Pingtung University of Science and Technology,Pingtung,Taiwan
Abstract:

Background

Chicken anemia virus (CAV), the causative agent chicken anemia, is the only member of the genus Gyrovirus of the Circoviridae family. CAV is an immune suppressive virus and causes anemia, lymph organ atrophy and immunodeficiency. The production and biochemical characterization of VP1 protein and its use in a subunit vaccine or as part of a diagnostic kit would be useful to CAV infection prevention.

Results

Significantly increased expression of the recombinant full-length VP1 capsid protein from chicken anemia virus was demonstrated using an E. coli expression system. The VP1 gene was cloned into various different expression vectors and then these were expressed in a number of different E. coli strains. The expression of CAV VP1 in E. coli was significantly increased when VP1 was fused with GST protein rather than a His-tag. By optimizing the various rare amino acid codons within the N-terminus of the VP1 protein, the expression level of the VP1 protein in E. coli BL21(DE3)-pLysS was further increased significantly. The highest protein expression level obtained was 17.5 g/L per liter of bacterial culture after induction with 0.1 mM IPTG for 2 h. After purification by GST affinity chromatography, the purified full-length VP1 protein produced in this way was demonstrated to have good antigenicity and was able to be recognized by CAV-positive chicken serum in an ELISA assay.

Conclusions

Purified recombinant VP1 protein with the gene's codons optimized in the N-terminal region has potential as chimeric protein that, when expressed in E. coli, may be useful in the future for the development of subunit vaccines and diagnostic tests.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号